Neurocrine Biosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
/ 
Frequently asked questions
To buy Neurocrine Biosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Neurocrine Biosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Neurocrine Biosciences Inc. is NBIX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Neurocrine Biosciences Inc. has its primary listing on NASDAQ. You can trade Neurocrine Biosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Neurocrine Biosciences Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Neurocrine Biosciences Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Neurocrine Biosciences Inc. or others.